These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35026538)

  • 61. Critical illness myopathy: what is happening?
    Friedrich O
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):403-9. PubMed ID: 16778569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles.
    Z'Graggen WJ; Brander L; Tuchscherer D; Scheidegger O; Takala J; Bostock H
    Clin Neurophysiol; 2011 Apr; 122(4):834-41. PubMed ID: 21044861
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of neurophysiological abnormality in prolonged critical illness.
    Coakley JH; Nagendran K; Yarwood GD; Honavar M; Hinds CJ
    Intensive Care Med; 1998 Aug; 24(8):801-7. PubMed ID: 9757924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study.
    Guarneri B; Bertolini G; Latronico N
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):838-41. PubMed ID: 18339730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early detection of ICU-acquired weakness in septic shock patients ventilated longer than 72 h.
    Attwell C; Sauterel L; Jöhr J; Piquilloud L; Kuntzer T; Diserens K
    BMC Pulm Med; 2022 Dec; 22(1):466. PubMed ID: 36474276
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications.
    Rodriguez B; Larsson L; Z'Graggen WJ
    Curr Treat Options Neurol; 2022; 24(4):173-182. PubMed ID: 35370393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Critical illness myopathy and neuropathy.
    Latronico N; Peli E; Botteri M
    Curr Opin Crit Care; 2005 Apr; 11(2):126-32. PubMed ID: 15758592
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006832. PubMed ID: 19160304
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measurement of muscle strength in the intensive care unit.
    Bittner EA; Martyn JA; George E; Frontera WR; Eikermann M
    Crit Care Med; 2009 Oct; 37(10 Suppl):S321-30. PubMed ID: 20046117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness.
    Fletcher SN; Kennedy DD; Ghosh IR; Misra VP; Kiff K; Coakley JH; Hinds CJ
    Crit Care Med; 2003 Apr; 31(4):1012-6. PubMed ID: 12682465
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dysregulation of sodium channel gating in critical illness myopathy.
    Teener JW; Rich MM
    J Muscle Res Cell Motil; 2006; 27(5-7):291-6. PubMed ID: 16874452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation.
    Polster A; Nelson BR; Olson EN; Beam KG
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):10986-91. PubMed ID: 27621462
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Motor excitability in myopathy.
    Liepert J; Schoser BG; Weiller C
    Clin Neurophysiol; 2004 Jan; 115(1):85-9. PubMed ID: 14706473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impaired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle.
    Banduseela VC; Chen YW; Kultima HG; Norman HS; Aare S; Radell P; Eriksson LI; Hoffman EP; Larsson L
    Physiol Genomics; 2013 Jun; 45(12):477-86. PubMed ID: 23572537
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Critical illness neuropathy and myopathy.
    Gutmann L; Gutmann L
    Arch Neurol; 1999 May; 56(5):527-8. PubMed ID: 10328246
    [No Abstract]   [Full Text] [Related]  

  • 77. Weak by the machines: muscle motor protein dysfunction - a side effect of intensive care unit treatment.
    Friedrich O; Diermeier S; Larsson L
    Acta Physiol (Oxf); 2018 Jan; 222(1):. PubMed ID: 28387014
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy--a reappraisal.
    Trojaborg W; Weimer LH; Hays AP
    Clin Neurophysiol; 2001 Sep; 112(9):1586-93. PubMed ID: 11514240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical approach to the weak patient in the intensive care unit.
    Dhand UK
    Respir Care; 2006 Sep; 51(9):1024-40; discussion 1040-1. PubMed ID: 16934166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Critical illness polyneuropathy and myopathy in a rural area in Vietnam.
    Nguyen The L; Nguyen Huu C
    J Neurol Sci; 2015 Oct; 357(1-2):276-81. PubMed ID: 26276515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.